Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Bullboard Posts
Post by Dachs1on Feb 01, 2014 11:00am
89 Views
Post# 22161786

AMEX Listing Requirements?

AMEX Listing Requirements?
  1. Standard 1

    • The AMEX requires companies to have $750,000 in pre-tax income in the two most recent fiscal years. In addition, the minimum price of its stock must be $3 and public float must have a market value of $3 million. Public float refers to shares of stock owned by the public and not by company directors, officers or controlling interest investors. In total, the company’s shareholder equity must be at least $4 million.

    Standard 2

    • Similar to standard 1, the company must have a stock price of at least $3. However, the company does not have to meet income requirements. Therefore, a company can make any amount of money to gain listing on the AMEX as long as it meets the other criteria in standard 2. In addition, its public float must be at least $15 million with at least $4 million in shareholder equity. Shareholder equity is the net worth of the company--that is, the difference between assets and liabilities. Lastly, AMEX requires companies to provide at least two years of operating history.

       

      1. Standard 3

        • Under this standard, the company needs to meet a minimum of $50 million in market capitalization. Market capitalization refers to the market price of the entire company. This is calculated by multiplying the number of shares in investor hands by the market price of the stock. Similar to standards 1 and 2, the company must meet a minimum $15 million market value public float and a minimum of $4 million in shareholder equity. Lastly, its share price must be at least $2.

        Standard 4

        • The fourth standard has the highest monetary requirements of all standards. In this case, the company must have either $75 million in market capitalization or at least $75 million in revenue and $75 million in assets. In addition, the public float must have a minimum value of $20 million with a share price of at least $2.


Bullboard Posts